Valaciclovir for Epstein-Barr virus suppression in moderate-to-severe COPD (EViSCO): an 8-week, randomised, double-blind, placebo-controlled trial.

Title: Valaciclovir for Epstein-Barr virus suppression in moderate-to-severe COPD (EViSCO): an 8-week, randomised, double-blind, placebo-controlled trial.
Author(s): Dermot Linden
Institution: Queen's University Belfast
Poster: Click to view poster
Category: COPD
Abstract: